BHVN · Biohaven Ltd
United States · RS rating 26 · As of 2026-10-14
| Price | 10.93 USD |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 21 / 17 / 22 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 34 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +26.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.6% |
| Market cap (USD) | $1.6B |